Congratulations to Dr. Andrew Mason on being named the recipient of the 2017 Outstanding PBC Researc
Congratulations to the 2017 recipient of the Outstanding PBC Research Award – Dr. Andrew Mason, Co-Director of the Centre for Excellence for Gastrointestinal Inflammation & Immunity Research, University of Alberta and CNTRP Project 5 Investigator. Canadian PBC Society recognizes Dr. Andrew Mason for his contribution and dedication to Primary Biliary Cholangitis (PBC) research and his ongoing commitment to his PBC patients. A world leader in PBC research and treatment, he has worked tirelessly on behalf of PBC patients. For over a decade, he has focused his research on establishing a link between the human betaretrovirus (HBRV) and PBC.
Dr. Mason’s patients said:
“Dr Mason was instrumental in developing treatment for PBC; he has worked extensively with fibroscan, transplant, gene research, patient care and education. His years in England, the US and ultimately in Canada at the University of Alberta have provided a wealth of new information on PBC and it’s treatment”
“Dr Mason attends our PBC support meetings and provides education about this illness to the general public.”
“Dr Mason has always treated me with respect and I am so fortunate to have him as my doctor.”
Join us in congratulating Dr. Andrew Mason!